Bioequivalence Studies: What FDA Requires Manufacturers to Prove
Posted On February 22, 2026 1The FDA requires generic drug manufacturers to prove bioequivalence through strict pharmacokinetic studies, ensuring their products match the brand-name drug in absorption and effectiveness. This process ensures safety, efficacy, and cost savings for patients.
Categories